Show simple item record

dc.contributor.advisorVergara Streinsberger, Maria Ines 
dc.creatorHernandez Beltran, Natalia 
dc.date.accessioned2013-08-09T14:16:53Z
dc.date.available2013-08-09T14:16:53Z
dc.date.created2013-07-17
dc.date.issued2013
dc.identifier.urihttp://repository.urosario.edu.co/handle/10336/4604
dc.descriptionLas infecciones del sistema nervioso son importantes fuentes de morbilidad y mortalidad en el mundo, debido a diferentes factores como son el amplio uso de antibióticos que aunque contribuyen con éxito al manejo de infecciones, pero el mal uso por automedicación o tratamientos incompletos favorecen la emergencia de organismos resistentes y la existencia de “mimos infecciosos” que incluyen el síndrome de reconstitución inflamatoria (IRIS). Adicionalmente el crecimiento de las poblaciones inmunocomprometidas por el síndrome de inmunodeficiencia adquirida (SIDA) y por tratamientos agresivos para trasplante sólido o hematopoyético han mejorado la sobrevida de diferentes tipos de malignidades y alteraciones reumatológicas pero son poblaciones que tienen más susceptibilidad a contraer infecciones y encefalitis mediadas inmunológicamente, como son la encefalomielitis diseminada aguda (ADEM) o la encefalitis contra el receptor de N-metil-D aspartato (NMDA).
dc.description.abstractsystem nervous infections are important sources of morbidity and mortality in the world, due to different factors since they are the wide use of antibiotics that though they contribute successfully to the managing of infections, but the evil use for auto medication or incomplete treatments favor the emergency of resistant organisms and the existence of " infectious caresses " that include the syndrome of inflammatory reconstitution (IRIS). Additional the growth of the populations immunodeficiency syndrome acquired (AIDS) and for aggressive treatments for solid transplant or hematic have improved the survival of different types of malices and alterations rheumatologic but they are populations who have more susceptibility to contract system neurvous infections and encephalitis happened immunologic , since it is the spread sharp encefalomielitis (ADEM) or the encephalitis against the receptor of N-metil-D aspartato (NMDA).
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectneuroinfeccion
dc.subjecturgencias
dc.titleEnfoque del paciente con sospecha de neuroinfección en urgencias
dc.typemasterThesis
dc.publisherUniversidad del Rosario
dc.creator.degreeEspecialista en Neurología
dc.publisher.programEspecialización en Neurología
dc.publisher.departmentFacultad de Medicina
dc.subject.keywordneuroinfection
dc.subject.keywordemergency
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.subject.decsANTIBIÓTICOS
dc.subject.decsENCEFALITIS
dc.subject.decsENCEFALOMIELITIS AGUDA DISEMINADA
dc.subject.decsINFECCIONES DEL SISTEMA NERVIOSO CENTRAL
dc.subject.decsINMUNOLOGÍA – INVESTIGACIONES
dc.subject.decsNEUROLOGÍA – INVESTIGACIONES
dc.subject.decsRECEPTORES DE N-METIL-D-ASPARTATO
dc.type.spaTrabajo de grado
dc.rights.accesoAbierto (Texto completo)
dc.type.hasVersioninfo:eu-repo/semantics/acceptedVersion
dc.source.bibliographicCitation1. Pruitt A. Neurologic infectious disease emergencies. Neurol clinic 2012;30: 129-159.
dc.source.bibliographicCitation2. Van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic
dc.source.bibliographicCitation3. Cabellos C, Verdquer R, Olmo M, et al. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine 2009;88:115–9.
dc.source.bibliographicCitation4. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993;328:21–8.
dc.source.bibliographicCitation5. Kourbeti IS, Jacobs AV, Koslow M, et al. Risk factors associated with postcraniotomy meningitis. Neurosurgery 2007;60:317–25.
dc.source.bibliographicCitation6. Walker M, Zunt JR. Parasitic CNS infections in immunocompromised hosts. Clin
dc.source.bibliographicCitation7. Pruitt AA. Central nervous system infections in cancer patients. Semin Neurol 2010;30:296–310.
dc.source.bibliographicCitation8. Ziai WC, Lewin JJ III. Update in the diagnosis and management of central nervous system infections. Neurol Clin 2008;26:427–68.
dc.source.bibliographicCitation9. Roos K, Tyler KL. Meningitis, encephalitis, brain abscess and empyema. In:Hauser SL, Josephson SA, editors. Harrison’s neurology in clinical medicine.2nd edition. New York: McGraw-Hill; 2010. p. 451–83
dc.source.bibliographicCitation10. Honda H, Warren DK. Central nervous system infections: meningitis and brain abscess. Infect Dis Clin North Am 2009;23:609–23.
dc.source.bibliographicCitation14. Mace SE. CNS infections as a cause of an altered mental status? What is the pathogen growing in your CNS? Emerg Med Clin North Am 2010;28:535–70.
dc.source.bibliographicCitation12. Fitch MT, Abrahamian FM, Moran GJ, et al. Emergency department management of meningitis and encephalitis. Infect Dis Clin North Am 2008;22:33–52.
dc.source.bibliographicCitation13. Brivet FG, Ducuing S, Jacobs F, et al. Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach. Intensive Care Med 2005;31:1654–60.
dc.source.bibliographicCitation14. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267–84.
dc.source.bibliographicCitation15. Nudelman Y, Tunkel AR. Bacterial meningitis: epidemiology, pathogenesis and management update. Drugs 2009;69:2577–96.
dc.source.bibliographicCitation15. Abba K, Ramaratnam S, Ranganathan LN. Antihelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010;3:CD000215.
dc.source.bibliographicCitation17. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351: 1741–51.
dc.source.bibliographicCitation18. Carrera E, Claassen J, Oddo ML, et al. Continuous electroencephalographic monitoring of critically ill patients with CNS infections. Arch Neurol 2008;65: 1612–8
dc.source.bibliographicCitation19. Granerod J, Cunningham R, Zuckerman M, et al. Causality in acute encephalitis: defining aetiologies. Epidemiol Infect 2010;138:783–800.
dc.source.bibliographicCitation20. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associatedencephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127(pt 3):701–12.
dc.source.bibliographicCitation21. Seeley WW, Marth FM, Holmes TM, et al. Post-transplant acute limbic encephalitis. Neurology 2007;69:156–65.
dc.source.bibliographicCitation22. Pru¨ss H, Dalmau J, Harms L, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010;75:1735–9.
dc.source.bibliographicCitation23. Granerod J, Tam CC, Crowcroft NS, et al. Challenge of the unknown: a systematic review of acute encephalitis in non-outbreak situations. Neurology 2010;75: 924–32
dc.source.bibliographicCitation24. Tseng JH, Tseng MY. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 2006;65:557–62.
dc.source.bibliographicCitation25. Osborn MK, Steinberg JP. Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis 2007;7:662–7
dc.source.bibliographicCitation26. . Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90–4.
dc.source.bibliographicCitation27. Pruitt AA, Rubin RH, Karchmer AW, et al. Neurological complications of bacterial endocarditis. Medicine (Baltimore) 1978;57:329–43.
dc.source.bibliographicCitation28. Vikram HR, Buencosejo J, Hasbun R, et al. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003;290:3207–14.
dc.source.bibliographicCitation29. Carson KB, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009; 113:4834–40.
dc.source.bibliographicCitation30. Brickelmaiaer M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrobial Agents Chemother 2009;53:1840–9.
dc.source.bibliographicCitation31. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol 2008;28:105–20.
dc.source.bibliographicCitation32. Darouiche RO. Spinal epidural abscess. N Engl J Med 2006;355:2012–20.
dc.source.bibliographicCitation33. Pradilla G, Nagahama Y, Spivak AM, et al. Spinal epidural abscess: current diagnosis and management. Curr Infect Dis Rep 2010;12:484–91.
dc.source.bibliographicCitation34. Sendi P, Bregenzer T, Zimmerli W. Spinal epidural abscess in clinical practice. QJM 2008;101:1–12.
dc.source.bibliographicCitation35. Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev 2000;23:175–204.
dc.source.bibliographicCitation36. Pradilla G, Ardila GP, Hsu W, et al. Epidural abscesses of the CNS. Lancet Neurol 2009;8:292–300
dc.source.bibliographicCitation37. Moellering RC Jr, Abbott GF, Ferraro MJ. Case Records of the MGH. Case 2- 2011: a 30-year-old woman with shock after treatment of a furuncle. N Engl J Med 2011;364:266–75.
dc.source.bibliographicCitation38. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309–17.
dc.format.tipoDocumento
dc.rights.ccAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rights.licenciaEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARÁGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/2.5/co/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/2.5/co/